InvestorsHub Logo
Followers 57
Posts 11397
Boards Moderated 0
Alias Born 02/09/2009

Re: knuts4oe post# 387

Tuesday, 11/01/2022 2:09:40 PM

Tuesday, November 01, 2022 2:09:40 PM

Post# of 547
“Oravax is based on cutting edge technology from Oramed Pharmaceuticals & Premas Biotech.”

MyMD’s 10-Q for June 30, 2021: MyMD shows an investment in Oravax valued at $1,500,000.

Oravax uses Premas’ C-Crypt technology, and uses Oramed’s POD technology.

https://ora-vax.com
https://www.premasbiotech.com
https://oramed.com

Thanks for tracking developments, knuts4oe
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MYMD News